1267P Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
| Autor: | Melia, M. Riudavets, Vasseur, D., Aldea, M., Lamberts, V., Suarez, M. Dorta, Naltet, C., Jovelet, C., Grecea, A., Romano, P. Martin, Lacroix, L., Lavaud, P., Gazzah, A., Morris, C., Howarth, K., Barlesi, F., Soria, J-C., Massard, C., Planchard, D., Besse, B., Mezquita, L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S991-S991 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|